The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Open accessAbstract
BACKGROUND: Neurostimulation of the subthalamic nucleus reduces levodopa-related motor complications in advanced Parkinson's disease. We compared this treatment plus medication with medical management. METHODS: In this randomized-pairs trial, we enrolled 156 patients with advanced Parkinson's disease and severe motor symptoms. The primary end points were the changes from baseline to six months in the quality of life, as assessed by the Parkinson's Disease Questionnaire (PDQ-39), and the severity of symptoms without medication, according to the Unified Parkinson's Disease Rating Scale, part III (UPDRS-III). RESULTS: Pairwise comparisons showed that neurostimulation, as compared with medication alone, caused greater improvements from baseline to six months in the PDQ-39 (50 of 78 pairs, P=0.02) and the UPDRS-III (55 of 78, P<0.001), with mean improvements of 9.5 and 19.6 points, respectively. Neurostimulation resulted in improvements of 24 to 38 percent in the PDQ-39 subscales for mobility, activities of daily living, emotional well-being, stigma, and bodily discomfort. Serious adverse events were more common with neurostimulation than with medication alone (13 percent vs. 4 percent, P<0.04) and included a fatal intracerebral hemorrhage. The overall frequency of adverse events was higher in the medication group (64 percent vs. 50 percent, P=0.08). CONCLUSIONS: In this six-month study of patients under 75 years of age with severe motor complications of Parkinson's disease, neurostimulation of the subthalamic nucleus was more effective than medical management alone. (ClinicalTrials.gov number, NCT00196911 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
Self-citationElectrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853
Self-citationRascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
What contributes to quality of life in patients with Parkinson's disease?
Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.308 · Cited by 1,380
Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995) · Quality of Life Research · doi:10.1007/bf02260863 · Cited by 1,204
Cited by
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Weaver, F. M. (2009) · JAMA · doi:10.1001/jama.2008.929 · Cited by 1,525
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Pharmacological Treatment of Parkinson Disease: A Review
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,498
Neurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430
Self-citationPallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907083 · Cited by 1,355
Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease
Benabid, A. L., Chabardes, S., Mitrofanis, J., & Pollak, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70291-6 · Cited by 1,285
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
Self-citationKaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., Bland, R. J., Young, D., Strybing, K., Eidelberg, D., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60982-9 · Cited by 1,067
Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027
“…stimulation (square-wave impulses of 90 ms pulse width, 145 Hz and amplitudes of 4 V, electrodes negative against case), those stimulation parameters were chosen because of the extensive experience with neurostimulation for neurological disorders (Deuschl and Bain, 2002; Deuschl et al, 2006).”
BackgroundSelf-citationDeep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues
Bronstein, J. M., Tagliati, M., Alterman, R. L., Lozano, A. M., Volkmann, J., Stefani, A., Horak, F. B., Okun, M. S., Foote, K. D., Krack, P., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.260 · Cited by 971
Self-citationThe scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
Wang, Y., & Liu, T. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25358 · Cited by 878
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865
Self-citationBrain-Controlled Interfaces: Movement Restoration with Neural Prosthetics
Schwartz, A. B., Cui, X. T., Weber, D. J., & Moran, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.019 · Cited by 792
Odekerken, V. J., van Laar, T., Staal, M. J., Mosch, A., Hoffmann, C. F., Nijssen, P. C., Beute, G. N., van Vugt, J. P., Lenders, M. W., Contarino, M. F., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70264-8 · Cited by 763
Optogenetic investigation of neural circuits underlying brain disease in animal models
Tye, K. M., & Deisseroth, K. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3171 · Cited by 745
“, DBS in the subthalamic nucleus (STN), a part of the basal ganglia circuit, and in other targets has shown remarkable therapeutic effects for treatment of the motor impairments associated with Parkinson's diseas”
BackgroundWilliams, A., Gill, S., Varma, T., Jenkinson, C., Quinn, N., Mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70093-4 · Cited by 733
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70039-4 · Cited by 681
Lead-DBS: A toolbox for deep brain stimulation electrode localizations and visualizations
Horn, A., & Kühn, A. A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2014.12.002 · Cited by 667
Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M. O., Krause, M., Tronnier, V., Kloss, M., Schnitzler, A., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70114-5 · Cited by 651
Self-citationMechanisms of deep brain stimulation
Herrington, T. M., Cheng, J. J., & Eskandar, E. N. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00281.2015 · Cited by 551
“…2010; Greenberg et al. 2010; Mallet et al. 2008a Parkinson’s disease GPi, STN, (PPN) Deep Brain Stimulation for Parkinson’s Disease Study Group 2001; Deuschl et al. 2006; Deuschl and Agid 2013; Follett et al. 2010; Odekerken et al. 2013; Okun et al. 2012; Schuepbach et al. 2013; Schüpbach et al.…”
BackgroundDeep-Brain Stimulation for Parkinson's Disease
Okun, M. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1208070 · Cited by 541
Recent progress in flexible–wearable solar cells for self-powered electronic devices
Hashemi, S. A., Ramakrishna, S., & Aberle, A. G. (2020) · Energy & Environmental Science · doi:10.1039/c9ee03046h · Cited by 527
Fox, S. H., Katzenschlager, R., Lim, S., Ravina, B., Seppi, K., Coelho, M., Poewe, W., Rascol, O., Goetz, C. G., & Sampaio, C. (2011) · Movement Disorders · doi:10.1002/mds.23829 · Cited by 523
Self-citationA fronto–striato–subthalamic–pallidal network for goal-directed and habitual inhibition
Jahanshahi, M., Obeso, I., Rothwell, J. C., & Obeso, J. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4038 · Cited by 521
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Meng, Y., Hynynen, K., & Lipsman, N. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00418-z · Cited by 505
History, Applications, and Mechanisms of Deep Brain Stimulation
Miocinovic, S., Somayajula, S., Chitnis, S., & Vitek, J. L. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.45 · Cited by 496
Long-term outcomes of deep brain stimulation in Parkinson disease
Limousin, P., & Foltynie, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0145-9 · Cited by 480
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease
Ferraye, M. U., Debu, B., Fraix, V., Goetz, L., Ardouin, C., Yelnik, J., Henry-Lagrange, C., Seigneuret, E., Piallat, B., Krack, P., et al. (2010) · Brain · doi:10.1093/brain/awp229 · Cited by 477
Self-citationPathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schüpbach, M., D’Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., et al. (2008) · Brain · doi:10.1093/brain/awn214 · Cited by 472
Self-citationMoro, E., Lozano, A. M., Pollak, P., Agid, Y., Rehncrona, S., Volkmann, J., Kulisevsky, J., Obeso, J. A., Albanese, A., Hariz, M. I., et al. (2010) · Movement Disorders · doi:10.1002/mds.22735 · Cited by 468
Self-citationFabbrini, G., Brotchie, J. M., Grandas, F., Nomoto, M., & Goetz, C. G. (2007) · Movement Disorders · doi:10.1002/mds.21475 · Cited by 464
Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation
Castrioto, A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.182 · Cited by 455
The modulatory effect of adaptive deep brain stimulation on beta bursts in Parkinson’s disease
Tinkhauser, G., Pogosyan, A., Little, S., Beudel, M., Herz, D. M., Tan, H., & Brown, P. (2017) · Brain · doi:10.1093/brain/awx010 · Cited by 454
Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes
Weaver, F. M., Follett, K. A., Stern, M., Luo, P., Harris, C. L., Hur, K., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825dcdc1 · Cited by 452
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., & Aminoff, M. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c29356 · Cited by 445
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
Fasano, A., Daniele, A., & Albanese, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70049-2 · Cited by 437
Priorities in Parkinson's disease research
Meissner, W. G., Frasier, M., Gasser, T., Goetz, C. G., Lozano, A., Piccini, P., Obeso, J. A., Rascol, O., Schapira, A., Voon, V., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3430 · Cited by 436
Nanogenerators for smart cities in the era of 5G and Internet of Things
Zhao, X., Askari, H., & Chen, J. (2021) · Joule · doi:10.1016/j.joule.2021.03.013 · Cited by 436
Parkinson’s disease dementia: a neural networks perspective
Gratwicke, J., Jahanshahi, M., & Foltynie, T. (2015) · Brain · doi:10.1093/brain/awv104 · Cited by 435
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
Fasano, A., Romito, L. M., Daniele, A., Piano, C., Zinno, M., Bentivoglio, A. R., & Albanese, A. (2010) · Brain · doi:10.1093/brain/awq221 · Cited by 429
Parkinson's disease: The quintessential neuropsychiatric disorder
Weintraub, D., & Burn, D. J. (2011) · Movement Disorders · doi:10.1002/mds.23664 · Cited by 423
Clinical Approach to Parkinson's Disease: Features, Diagnosis, and Principles of Management
Massano, J., & Bhatia, K. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008870 · Cited by 422
Okun, M. S., Gallo, B. V., Mandybur, G., Jagid, J., Foote, K. D., Revilla, F. J., Alterman, R., Jankovic, J., Simpson, R., Junn, F., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70308-8 · Cited by 409
Adaptive deep brain stimulation for Parkinson’s disease using motor cortex sensing
Swann, N. C., de Hemptinne, C., Thompson, M. C., Miocinovic, S., Miller, A. M., Gilron, R., Ostrem, J. L., Chizeck, H. J., & Starr, P. A. (2018) · Journal of Neural Engineering · doi:10.1088/1741-2552/aabc9b · Cited by 389
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals
Jost, S. T., Kaldenbach, M., Antonini, A., Martinez‐Martin, P., Timmermann, L., Odin, P., Katzenschlager, R., Borgohain, R., Fasano, A., Stocchi, F., et al. (2023) · Movement Disorders · doi:10.1002/mds.29410 · Cited by 389
Self-citationStimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory
Stone, S. S. D., Teixeira, C. M., DeVito, L. M., Zaslavsky, K., Josselyn, S. A., Lozano, A. M., & Frankland, P. W. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3100-11.2011 · Cited by 384
Bilateral adaptive deep brain stimulation is effective in Parkinson's disease
Little, S., Beudel, M., Zrinzo, L., Foltynie, T., Limousin, P., Hariz, M., Neal, S., Cheeran, B., Cagnan, H., Gratwicke, J., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310972 · Cited by 385
Quantitative wearable sensors for objective assessment of Parkinson's disease
Maetzler, W., Domingos, J., Srulijes, K., Ferreira, J. J., & Bloem, B. R. (2013) · Movement Disorders · doi:10.1002/mds.25628 · Cited by 374
Current and experimental treatments of Parkinson disease: A guide for neuroscientists
Oertel, W., & Schulz, J. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13750 · Cited by 369
Self-citationZrinzo, L., Foltynie, T., Limousin, P., & Hariz, M. I. (2012) · Journal of Neurosurgery · doi:10.3171/2011.8.jns101407 · Cited by 366
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis
Tang, C. C., Poston, K. L., Eckert, T., Feigin, A., Frucht, S., Gudesblatt, M., Dhawan, V., Lesser, M., Vonsattel, J.-P., Fahn, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70002-8 · Cited by 354
Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kanovsky, P., et al. (2013) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03866.x · Cited by 348
Self-citationOxley, T. J., Opie, N. L., John, S. E., Rind, G. S., Ronayne, S. M., Wheeler, T. L., Judy, J. W., McDonald, A. J., Dornom, A., Lovell, T. J. H., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3428 · Cited by 339
Mood and behavioural effects of subthalamic stimulation in Parkinson's disease
Castrioto, A., Lhommée, E., Moro, E., & Krack, P. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70294-1 · Cited by 333
Self-citationDeep Brain Stimulation for Neurologic and Neuropsychiatric Disorders
Wichmann, T., & DeLong, M. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.022 · Cited by 331
Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations
Priori, A., Foffani, G., Rossi, L., & Marceglia, S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.013 · Cited by 331
A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder
Li, N., Baldermann, J. C., Kibleur, A., Treu, S., Akram, H., Elias, G. J. B., Boutet, A., Lozano, A. M., Al-Fatly, B., Strange, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16734-3 · Cited by 316
Therapeutic Deep Brain Stimulation in Parkinsonian Rats Directly Influences Motor Cortex
Li, Q., Ke, Y., Chan, D. C. W., Qian, Z.-M., Yung, K. K. L., Ko, H., Arbuthnott, G. W., & Yung, W.-H. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.032 · Cited by 312
Oswal, A., Beudel, M., Zrinzo, L., Limousin, P., Hariz, M., Foltynie, T., Litvak, V., & Brown, P. (2016) · Brain · doi:10.1093/brain/aww048 · Cited by 310
Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations
Martinez‐Martin, P., Jeukens‐Visser, M., Lyons, K. E., Rodriguez‐Blazquez, C., Selai, C., Siderowf, A., Welsh, M., Poewe, W., Rascol, O., Sampaio, C., et al. (2011) · Movement Disorders · doi:10.1002/mds.23834 · Cited by 308
Self-citationDeep brain stimulation: from neurology to psychiatry?
Krack, P., Hariz, M. I., Baunez, C., Guridi, J., & Obeso, J. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.07.002 · Cited by 306
Self-citationTreatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N., & Sawa, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.016 · Cited by 304
Boutet, A., Madhavan, R., Elias, G. J. B., Joel, S. E., Gramer, R., Ranjan, M., Paramanandam, V., Xu, D., Germann, J., Loh, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23311-9 · Cited by 301
Piezoelectric energy harvesters for biomedical applications
Ali, F., Raza, W., Li, X., Gul, H., & Kim, K.-H. (2019) · Nano Energy · doi:10.1016/j.nanoen.2019.01.012 · Cited by 300
Emerging therapies in Parkinson disease — repurposed drugs and new approaches
Elkouzi, A., Vedam-Mai, V., Eisinger, R. S., & Okun, M. S. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0155-7 · Cited by 300
Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours
Lhommée, E., Klinger, H., Thobois, S., Schmitt, E., Ardouin, C., Bichon, A., Kistner, A., Fraix, V., Xie, J., Aya Kombo, M., et al. (2012) · Brain · doi:10.1093/brain/aws078 · Cited by 296
Self-citationAbnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder
Beucke, J. C., Sepulcre, J., Talukdar, T., Linnman, C., Zschenderlein, K., Endrass, T., Kaufmann, C., & Kathmann, N. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.173 · Cited by 280
Closed-loop Neurostimulation: The Clinical Experience
Sun, F. T., & Morrell, M. J. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0280-3 · Cited by 286
Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease
Martínez-Fernández, R., Máñez-Miró, J. U., Rodríguez-Rojas, R., del Álamo, M., Shah, B. B., Hernández-Fernández, F., Pineda-Pardo, J. A., Monje, M. H. G., Fernández-Rodríguez, B., Sperling, S. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2016311 · Cited by 282
Tourette syndrome deep brain stimulation: A review and updated recommendations
Schrock, L. E., Mink, J. W., Woods, D. W., Porta, M., Servello, D., Visser‐Vandewalle, V., Silburn, P. A., Foltynie, T., Walker, H. C., Shahed‐Jimenez, J., et al. (2015) · Movement Disorders · doi:10.1002/mds.26094 · Cited by 282
Review: Deep brain stimulation in Parkinson’s disease
Groiss, S. J., Wojtecki, L., Südmeyer, M., & Schnitzler, A. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609339382 · Cited by 280
Self-citationToward an electrophysiological “sweet spot” for deep brain stimulation in the subthalamic nucleus
Horn, A., Neumann, W., Degen, K., Schneider, G., & Kühn, A. A. (2017) · Human Brain Mapping · doi:10.1002/hbm.23594 · Cited by 276
Self-citationParkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil
Thobois, S., Lhommée, E., Klinger, H., Ardouin, C., Schmitt, E., Bichon, A., Kistner, A., Castrioto, A., Xie, J., Fraix, V., et al. (2013) · Brain · doi:10.1093/brain/awt067 · Cited by 274
Self-citationEmerging technologies for improved deep brain stimulation
Cagnan, H., Denison, T., McIntyre, C., & Brown, P. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0244-6 · Cited by 272
Burchiel, K. J., McCartney, S., Lee, A., & Raslan, A. M. (2013) · Journal of Neurosurgery · doi:10.3171/2013.4.jns122324 · Cited by 270
Husch, A., V. Petersen, M., Gemmar, P., Goncalves, J., & Hertel, F. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.10.004 · Cited by 264
First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease
Magara, A., Bühler, R., Moser, D., Kowalski, M., Pourtehrani, P., & Jeanmonod, D. (2014) · Journal of Therapeutic Ultrasound · doi:10.1186/2050-5736-2-11 · Cited by 263
Coordinated reset has sustained aftereffects in Parkinsonian monkeys
Tass, P. A., Qin, L., Hauptmann, C., Dovero, S., Bezard, E., Boraud, T., & Meissner, W. G. (2012) · Annals of Neurology · doi:10.1002/ana.23663 · Cited by 262
Deep brain stimulation for Parkinson's disease
Hariz, M., & Blomstedt, P. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13541 · Cited by 256
Adaptive deep brain stimulation in a freely moving parkinsonian patient
Rosa, M., Arlotti, M., Ardolino, G., Cogiamanian, F., Marceglia, S., Di Fonzo, A., Cortese, F., Rampini, P. M., & Priori, A. (2015) · Movement Disorders · doi:10.1002/mds.26241 · Cited by 255
Whitmer, D., de Solages, C., Hill, B., Yu, H., Henderson, J. M., & Bronte-Stewart, H. (2012) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2012.00155 · Cited by 255
(2019) · International Review of Neurobiology · doi:10.1016/bs.irn.2019.10.004 · Cited by 253
MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety
Foltynie, T., Zrinzo, L., Martinez-Torres, I., Tripoliti, E., Petersen, E., Holl, E., Aviles-Olmos, I., Jahanshahi, M., Hariz, M., & Limousin, P. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.205542 · Cited by 252
Self-powered deep brain stimulation via a flexible PIMNT energy harvester
Hwang, G.-T., Kim, Y., Lee, J.-H., Oh, S., Jeong, C. K., Park, D. Y., Ryu, J., Kwon, H., Lee, S.-G., Joung, B., et al. (2015) · Energy & Environmental Science · doi:10.1039/c5ee01593f · Cited by 252
Opportunities of connectomic neuromodulation
Horn, A., & Fox, M. D. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117180 · Cited by 187
Powering implantable and ingestible electronics
Yang, S., Sencadas, V., You, S. S., Jia, N. Z., Srinivasan, S. S., Huang, H., Ahmed, A. E., Liang, J. Y., & Traverso, G. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009289 · Cited by 183
A clinical view on the development of technology‐based tools in managing Parkinson's disease
Maetzler, W., Klucken, J., & Horne, M. (2016) · Movement Disorders · doi:10.1002/mds.26673 · Cited by 162
Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease
Hickey, P., & Stacy, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00173 · Cited by 125
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease
Niethammer, M., Tang, C. C., LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Sarkar, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90133 · Cited by 124
Current applications and limitations of surgical treatments for movement disorders
Krack, P., Martinez‐Fernandez, R., del Alamo, M., & Obeso, J. A. (2017) · Movement Disorders · doi:10.1002/mds.26890 · Cited by 122
“The overall frequency of side effects, especially of serious adverse events, was higher in the surgical group.(15,38,39) The 2 available randomized controlled trials comparing STN-DBS with GPi-DBS yielded contradictory clinical findings,(16,17) with 1 concluding greater improvement in off-drug motor scores and Schwab…”
BackgroundResultInfluentialSelf-citationDeep brain stimulation of symptom-specific networks in Parkinson’s disease
Rajamani, N., Friedrich, H., Butenko, K., Dembek, T., Lange, F., Navrátil, P., Zvarova, P., Hollunder, B., de Bie, R. M. A., Odekerken, V. J. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48731-1 · Cited by 118
“…run the algorithm with a symptom pro fi le of a typical tremor-dominant patient with high weighting of tremor and lower weighting of bradykinetic-rigid symptoms, which would favor settings that maximally target the tremor connections from primary motor cortex and cerebellum (Supplementary Movie 1).”
InfluentialSelf-citationEffects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
Goldman, J. G., Goetz, C. G., Brandabur, M., Sanfilippo, M., & Stebbins, G. T. (2008) · Movement Disorders · doi:10.1002/mds.22322 · Cited by 109
Mind Reading and Writing: The Future of Neurotechnology
Roelfsema, P. R., Denys, D., & Klink, P. C. (2018) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2018.04.001 · Cited by 107
Tremor: Clinical Features, Pathophysiology, and Treatment
Elble, R. J. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.003 · Cited by 102
“subthalamus are effective treatments for tremor and also reduce bradykinesia and rigidity.(52,53) In the subthalamic area neighboring the ventrolateral thalamus, the subthalamus, zona incerta, pallidothalamic fibers, and cerebellothalamic fibers probably all participate in tremorogenesis.”
BackgroundMorgante, L., Morgante, F., Moro, E., Epifanio, A., Girlanda, P., Ragonese, P., Antonini, A., Barone, P., Bonuccelli, U., Contarino, M. F., et al. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.12.013 · Cited by 94
Deep brain stimulation: current and future perspectives
Awan, N. R., Lozano, A., & Hamani, C. (2009) · Neurosurgical Focus · doi:10.3171/2009.4.focus0982 · Cited by 83
Metadata
- Authors
- Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., Gruber, D., Hamel, W., Herzog, J., Hilker, R., Klebe, S., Kloß, M., Koy, J., Krause, M., Kupsch, A., Lorenz, D., Lorenzl, S., Mehdorn, H. M., Moringlane, J. R., Oertel, W., Pinsker, M. O., Reichmann, H., Reuß, A., Schneider, G.-H., Schnitzler, A., Steude, U., Sturm, V., Timmermann, L., Tronnier, V., Trottenberg, T., Wojtecki, L., Wolf, E., Poewe, W., & Voges, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-08-31
- Volume
- 355
- Issue
- 9
- Pages
- 896-908
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2149476088
- Cited by
- 2,944
- References
- 32
- FWCI
- 59.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.